- Home
- IPHA vs RMNI Comparison
IPHA vs RMNI Comparison
Compare IPHA & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- RMNI
- Stock Information
- Founded
- IPHA 1999
- RMNI 2005
- Country
- IPHA France
- RMNI United States
- Employees
- IPHA N/A
- RMNI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- RMNI Business Services
- Sector
- IPHA Health Care
- RMNI Consumer Discretionary
- Exchange
- IPHA Nasdaq
- RMNI Nasdaq
- Market Cap
- IPHA 148.3M
- RMNI 245.5M
- IPO Year
- IPHA 2019
- RMNI N/A
- Fundamental
- Price
- IPHA $1.79
- RMNI $2.68
- Analyst Decision
- IPHA Strong Buy
- RMNI Buy
- Analyst Count
- IPHA 1
- RMNI 2
- Target Price
- IPHA $11.50
- RMNI $6.00
- AVG Volume (30 Days)
- IPHA 779.8K
- RMNI 538.6K
- Earning Date
- IPHA 09-12-2024
- RMNI 02-26-2025
- Dividend Yield
- IPHA N/A
- RMNI N/A
- EPS Growth
- IPHA N/A
- RMNI N/A
- EPS
- IPHA N/A
- RMNI N/A
- Revenue
- IPHA $36,202,722.00
- RMNI $426,650,000.00
- Revenue This Year
- IPHA N/A
- RMNI N/A
- Revenue Next Year
- IPHA $101.65
- RMNI N/A
- P/E Ratio
- IPHA N/A
- RMNI N/A
- Revenue Growth
- IPHA N/A
- RMNI N/A
- 52 Week Low
- IPHA $1.29
- RMNI $1.53
- 52 Week High
- IPHA $3.51
- RMNI $3.43
- Technical
- Relative Strength Index (RSI)
- IPHA 45.92
- RMNI 56.80
- Support Level
- IPHA $1.64
- RMNI $2.50
- Resistance Level
- IPHA $1.87
- RMNI $2.86
- Average True Range (ATR)
- IPHA 0.12
- RMNI 0.19
- MACD
- IPHA -0.04
- RMNI -0.02
- Stochastic Oscillator
- IPHA 28.66
- RMNI 45.24
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc is a provider of enterprise software support products and services and a third-party support provider for Oracle and SAP software products based in the United States. The company offers solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. Some of its products include Oracle E-business suite, Oracle Database, Peoplesoft, SAP business suite, and others. The company derives maximum revenue from United states.